ZA201908006B - Targeted drug rescue with novel compositions, combinations, and methods thereof - Google Patents

Targeted drug rescue with novel compositions, combinations, and methods thereof

Info

Publication number
ZA201908006B
ZA201908006B ZA2019/08006A ZA201908006A ZA201908006B ZA 201908006 B ZA201908006 B ZA 201908006B ZA 2019/08006 A ZA2019/08006 A ZA 2019/08006A ZA 201908006 A ZA201908006 A ZA 201908006A ZA 201908006 B ZA201908006 B ZA 201908006B
Authority
ZA
South Africa
Prior art keywords
combinations
methods
novel compositions
targeted drug
drug rescue
Prior art date
Application number
ZA2019/08006A
Other languages
English (en)
Inventor
Vepachedu Sreenivasarao
J Moebius Hans
Bespalov Anton
Original Assignee
Exciva GmbH
Vepachedu Sreenivasarao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2017/048748 external-priority patent/WO2018039642A1/fr
Application filed by Exciva GmbH, Vepachedu Sreenivasarao filed Critical Exciva GmbH
Publication of ZA201908006B publication Critical patent/ZA201908006B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ZA2019/08006A 2017-05-04 2019-12-02 Targeted drug rescue with novel compositions, combinations, and methods thereof ZA201908006B (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201762501696P 2017-05-04 2017-05-04
PCT/US2017/048748 WO2018039642A1 (fr) 2016-08-26 2017-08-25 Compositions et procédés associés
TW106129169A TW201815387A (zh) 2016-08-26 2017-08-28 組成物及其方法
US201862634162P 2018-02-22 2018-02-22
US201862636099P 2018-02-27 2018-02-27
US201862635554P 2018-02-27 2018-02-27
US201862636171P 2018-02-28 2018-02-28
PCT/US2018/030978 WO2018204713A1 (fr) 2017-05-04 2018-05-03 Targeted drug rescue avec de nouvelles compositions, associations et procédés correspondants

Publications (1)

Publication Number Publication Date
ZA201908006B true ZA201908006B (en) 2021-04-28

Family

ID=65431106

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2019/08006A ZA201908006B (en) 2017-05-04 2019-12-02 Targeted drug rescue with novel compositions, combinations, and methods thereof

Country Status (13)

Country Link
EP (1) EP3618819A4 (fr)
JP (2) JP7514078B2 (fr)
KR (2) KR102444803B1 (fr)
CN (1) CN110831584B (fr)
AU (2) AU2018261654A1 (fr)
BR (1) BR112019022902A2 (fr)
CA (2) CA3138116A1 (fr)
IL (1) IL270326B2 (fr)
MA (1) MA49464A (fr)
RU (1) RU2760558C9 (fr)
TW (1) TWI787260B (fr)
WO (1) WO2018204713A1 (fr)
ZA (1) ZA201908006B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3618819A4 (fr) * 2017-05-04 2021-01-20 Exciva GmbH Targeted drug rescue avec de nouvelles compositions, associations et procédés correspondants
AU2020241611A1 (en) * 2019-03-18 2021-11-04 Avanir Pharmaceuticals, Inc. Methods of treating negative symptoms of schizophrenia using deuterated dextromethorphan and quinidine
KR102820594B1 (ko) * 2019-06-06 2025-06-16 제이에스알 가부시키가이샤 감방사선성 수지 조성물, 레지스트 패턴 형성 방법 및 화합물
IL312785B2 (en) 2020-05-19 2026-06-01 Cybin Irl Ltd Deuterated tryptamine derivatives and methods of use
CN116473077B (zh) * 2023-05-08 2025-04-11 广东方中高新材料有限公司 一种n,n配位的镓配合物抗菌剂的合成和应用
CN116473073A (zh) * 2023-05-08 2023-07-25 广东方中高新材料有限公司 一种含镓配合物的吡唑醚菌酯增效悬浮制剂及其制备方法
CN119432479B (zh) * 2023-08-04 2025-10-03 中国石油天然气股份有限公司 柴油机润滑油组合物及其制备方法
CN120987847B (zh) * 2024-11-29 2026-02-17 江苏恩华药业股份有限公司 一种氢溴酸右美沙芬的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241065A (en) * 1979-07-02 1980-12-23 E. I. Du Pont De Nemours And Company Fluoro analogs of hydrocodone and oxycodone useful as analgesics, narcotic antagonists or both
US4950658A (en) * 1988-12-06 1990-08-21 Board Of Trustees Of Southern Illinois Univ. Method of medical treatment of Alzheimer's disease
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
US6207674B1 (en) * 1999-12-22 2001-03-27 Richard A. Smith Dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants
US6335371B1 (en) * 2000-11-28 2002-01-01 Orion Corporation Method for inducing cognition enhancement
TWI326214B (en) * 2002-07-17 2010-06-21 Avanir Pharmaceuticals Inc Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
US20070099947A1 (en) * 2005-11-03 2007-05-03 Alkermes, Inc. Methods and compositions for the treatment of brain reward system disorders by combination therapy
WO2007092329A2 (fr) 2006-02-03 2007-08-16 Avanir Pharmaceuticals Compositions pharmaceutiques comprenant du dextrométhorphane et de la quinidine pour le traitement de la dépression, de l'anxiété et des troubles neurodégénératifs
MX370608B (es) * 2007-05-01 2019-12-18 Concert Pharmaceuticals Inc Compuestos de morfinano.
RU2497819C2 (ru) * 2007-05-21 2013-11-10 Ривайва Фармасьютикалс, Инк. Композиции, синтез и способы применения атипичных нейролептиков на основе хинолина
US8017623B2 (en) * 2008-07-03 2011-09-13 Trinity Laboratories, Inc. Dextromethorphan hydrochloride
US9737531B2 (en) * 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
US10716784B2 (en) * 2013-03-07 2020-07-21 Mindlab LLC Pain medicine combination and uses thereof
EP2972329A2 (fr) * 2013-03-15 2016-01-20 Kinemed, Inc. Biomarqueurs
TWI869633B (zh) * 2014-09-14 2025-01-11 美商阿瓦尼爾製藥股份有限公司 用於治療失智症中躁動行為之包含右旋美索芬(dextromethorphan)化合物及奎尼丁(quinidine)的藥學組成物
CA3034895A1 (fr) * 2016-08-26 2018-03-01 Exciva Ug (Haftungsbeschrankt) Compositions et procedes associes
EP3618819A4 (fr) * 2017-05-04 2021-01-20 Exciva GmbH Targeted drug rescue avec de nouvelles compositions, associations et procédés correspondants

Also Published As

Publication number Publication date
JP2020518617A (ja) 2020-06-25
IL270326B2 (en) 2023-02-01
TWI787260B (zh) 2022-12-21
CA3138116A1 (fr) 2018-11-08
AU2018261654A1 (en) 2019-11-14
KR20210130827A (ko) 2021-11-01
CA3062452C (fr) 2023-10-24
RU2019137004A (ru) 2021-06-04
WO2018204713A1 (fr) 2018-11-08
TW201842902A (zh) 2018-12-16
AU2021215274A1 (en) 2021-09-02
RU2760558C9 (ru) 2022-02-22
MA49464A (fr) 2020-04-29
CA3062452A1 (fr) 2018-11-08
KR20200062078A (ko) 2020-06-03
BR112019022902A2 (pt) 2020-05-19
CN110831584B (zh) 2023-03-10
JP2023143940A (ja) 2023-10-06
JP7514078B2 (ja) 2024-07-10
EP3618819A1 (fr) 2020-03-11
AU2021215274B2 (en) 2022-11-03
CN110831584A (zh) 2020-02-21
IL270326B (en) 2022-10-01
IL270326A (fr) 2018-05-03
RU2760558C2 (ru) 2021-11-29
RU2019137004A3 (fr) 2021-06-04
EP3618819A4 (fr) 2021-01-20
KR102444803B1 (ko) 2022-09-19

Similar Documents

Publication Publication Date Title
IL270326B (en) Tdr with new preparations, combinations and their methods
IL290114A (en) Pharmaceutical preparations, their preparation and uses
PL3157901T3 (pl) Preparaty, ich wytwarzanie i zastosowanie, oraz odpowiednie składniki
GB201512215D0 (en) Agents,uses and methods
GB201705124D0 (en) Composition, method and use
GB201715769D0 (en) Methods, Compositions and uses relating thereto
GB2564511B (en) Composition, method and use
IL252397A0 (en) Pharmaceutical preparations, their preparation and uses
GB2560212B (en) Methods, compositions and uses relating thereto
HUE048394T2 (hu) Új triazolopirimidinon vagy triazolopyridinone származékok és ezek felhasználása
PL3229843T3 (pl) Kompozycja farmaceutyczna, wytwarzanie i zastosowanie tej kompozycji
HUE057073T2 (hu) Polibutadiének, azok elõállítása és alkalmazása
GB2577456B (en) Methods, compositions and uses relating thereto
GB201805016D0 (en) Composition, method and use
PL3386988T3 (pl) Nowe pochodne dihydropiranopirymidynonu i ich zastosowanie
GB2560213C (en) Methods, compositions and uses relating thereto
GB201715799D0 (en) Methods, compositions and uses relating thereto
ZA201906907B (en) Analytical and therapeutic methods and compositions, and uses thereof
HK40015233A (en) Targeted drug rescue with novel compositions, combinations, and methods thereof
GB201716557D0 (en) Composition, methods and uses
PT3484533T (pt) Hidrogel à base de sericina de seda, métodos e usos do mesmo
GB201616753D0 (en) Methods, compositions and uses relating thereto
GB201616648D0 (en) Methods, compositions and uses relating thereto
GB201616645D0 (en) Methods, compositions and uses relating thereto
GB201616647D0 (en) Methods, compositions and uses relating thereto